Cargando…

Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis

BACKGROUND: Hypertension is one of the leading causes of cardiovascular disease (CVD). A range of antihypertensive drugs exists, and their prices vary widely mainly due to patent rights. The objective of this study was to explore the cost-effectiveness of different generic antihypertensive drugs as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wisløff, Torbjørn, Selmer, Randi M, Halvorsen, Sigrun, Fretheim, Atle, Norheim, Ole F, Kristiansen, Ivar Sønbø
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353849/ https://www.ncbi.nlm.nih.gov/pubmed/22475076 http://dx.doi.org/10.1186/1471-2261-12-26

Ejemplares similares

Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
por: Fretheim, Atle, et al.
Publicado: (2012)

The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis
por: Fretheim, Atle, et al.
Publicado: (2003)

Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study
por: Bugge, Christoffer, et al.
Publicado: (2018)

Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs
por: Engebretsen, Ingrid, et al.
Publicado: (2022)

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave
por: Xue, Yiting, et al.
Publicado: (2010)

Decisions on statin therapy by patients’ opinions about survival gains: cross sectional survey of general practitioners
por: Halvorsen, Peder A., et al.
Publicado: (2015)

International variation in prescribing antihypertensive drugs: Its extent and possible explanations
por: Fretheim, Atle, et al.
Publicado: (2005)

Dynamic modelling of costs and health consequences of school closure during an influenza pandemic
por: Xue, Yiting, et al.
Publicado: (2012)

What professional activities do general practitioners find most meaningful? Cross sectional survey of Norwegian general practitioners
por: Halvorsen, Peder Andreas, et al.
Publicado: (2013)

Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change
por: Fretheim, Atle, et al.
Publicado: (2004)

Practice variation in surgical procedures and IUD-insertions among general practitioners in Norway – a longitudinal study
por: Pahle, Andreas Saxlund, et al.
Publicado: (2017)

Phase- and gender-specific, lifetime, and future costs of cancer: A retrospective population-based registry study
por: Bugge, Christoffer, et al.
Publicado: (2021)

Dynamic Modeling of Cost-effectiveness of Rotavirus Vaccination, Kazakhstan
por: Freiesleben de Blasio, Birgitte, et al.
Publicado: (2014)

Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
por: Mundal, Liv J, et al.
Publicado: (2018)

Economic cost of primary prevention of cardiovascular diseases in Tanzania
por: Ngalesoni, Frida, et al.
Publicado: (2015)

Rational Prescribing in Primary care (RaPP): process evaluation of an intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs
por: Fretheim, Atle, et al.
Publicado: (2006)

Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting
por: Johannessen, Tonje R., et al.
Publicado: (2022)

Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey
por: Harmsen, Charlotte Gry, et al.
Publicado: (2012)

Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice
por: Harmsen, Charlotte Gry, et al.
Publicado: (2013)

Drugs Becoming Generics—The Impact of Genericization on the Market Performance of Antihypertensive Active Pharmaceutical Ingredients
por: Kovács, Bence, et al.
Publicado: (2021)

Evaluating costs and health consequences of sick leave strategies against pandemic and seasonal influenza in Norway using a dynamic model
por: Edwards, Christina Hansen, et al.
Publicado: (2019)

Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country – the case of Tanzania
por: Robberstad, Bjarne, et al.
Publicado: (2007)

Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]
por: Fretheim, Atle, et al.
Publicado: (2003)

The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway
por: Andreassen, A. Elizabeth S., et al.
Publicado: (2017)

Norwegian Physicians' Knowledge of and Opinions about Evidence-Based Medicine: Cross-Sectional Study
por: Ulvenes, Lidziya Vanahel, et al.
Publicado: (2009)

Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China
por: Huang, Tao, et al.
Publicado: (2022)

Effect of a pharmacist‐led intervention on adherence among patients with a first‐time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies
por: Hovland, Ragnar, et al.
Publicado: (2019)

Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
por: Wisløff, Torbjørn, et al.
Publicado: (2016)

Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania
por: Ngalesoni, Frida, et al.
Publicado: (2017)

Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
por: Tolla, Mieraf Taddesse, et al.
Publicado: (2016)

Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
por: Toverud, Else-Lydia, et al.
Publicado: (2010)

Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study
por: Ngalesoni, Frida N., et al.
Publicado: (2016)

Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey
por: Dahl, Rasmus, et al.
Publicado: (2007)

Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67
por: Desser, Arna S, et al.
Publicado: (2010)

Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway
por: Burger, Emily A, et al.
Publicado: (2017)

What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
por: Bugge, Christoffer, et al.
Publicado: (2021)

Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting
por: Korman, Max, et al.
Publicado: (2018)

Does the primary screening test influence women’s anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women
por: Burger, Emily A, et al.
Publicado: (2014)

Influenced from the start: anchoring bias in time trade-off valuations
por: Augestad, Liv Ariane, et al.
Publicado: (2016)

Physicochemical equivalence of generic antihypertensive medicines (EQUIMEDS): protocol for a quality of medicines assessment
por: Redfern, Julie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_74h22drp6jbh19ifqjoek2uja1